High Court Set To Determine Scope Of FCA

By Dave Nadler and David Yang, Dickstein Shapiro LLP, published on Law360 on December 10, 2015 Law360, New York (December 10, 2015, 9:33 AM ET) — In one of the most highly anticipated developments, on Dec. 4, 2015, the U.S. Supreme Court granted cert in U.S. ex rel. Escobar v. Universal Health Services Inc., 780 F.3d 504 (1st Cir. 2015), to resolve the long-standing circuit court split as to whether the implied certification theory is a viable approach for establishing liability under the civil False Claims Act. [Read More] 

Related Event

Now in its third successful year, American Conference Institute’s Advanced Forum on False Claims and Qui Tam Enforcement provides up-to-date guidance on the rapidly changing developments in the FCA legal landscape. As those boundaries fluctuate, companies must keep a close eye on this continually evolving area of the law. Take advantage of the opportunity to meet leading industry decision makers from:

• BAE Systems
• The Boeing Company
• Kellogg Brown & Root
• Lockheed Martin Corporation
• Medtronic, Inc.
• UnitedHealthcare
• University of Maryland Faculty Physicians Inc.

This comprehensive two day forum has been uniquely developed for in-house counsel, chief compliance officers and private practitioners to discuss the latest developments in this rapidly changing practice – along with practical tips for investing, defending and setting these cases. You will hear from companies that have settled FCA cases and get the chance to hear what they learned during the process.

Tags: False Claims, False Claims & Qui Tam Enforcement, Industry news, Qui Tam, U.S. Supreme Court